Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Cyclin-Dependent Kinases

Items 41-50 of 69

Page
per page
  1. Deferasirox
    A8639 Deferasirox
     3 Citation
    Summary: Oral iron chelator
      insoluble in H2O; ≥37.28 mg/mL
  2. Purvalanol B
    A8565 Purvalanol B
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/CDK2/CDK4 inhibitor
      ≥21.65 mg/mL
  3. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  4. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     6 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor
  5. BMS265246
    A8385 BMS265246
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL
  6. Palbociclib (PD0332991) Isethionate
    A8335 Palbociclib (PD0332991) Isethionate
     5 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥28.7 mg/mL
  7. AZD-5438
    A8326 AZD-5438
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK1/2/9 inhibitor
      insoluble in H2O; ≥18.55 mg/mL
  8. PD 0332991 (Palbociclib) HCl
    A8316 PD 0332991 (Palbociclib) HCl
     15 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor
      ≥14.48 mg/mL
  9. AT7519
    A5719 AT7519
    Target: Cyclin-Dependent Kinases
    Summary: Multi-CDK inhibitor
  10. BS-181 HCl
    A5700 BS-181 HCl
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor,highly selective
      insoluble in H2O; ≥20.85 mg/mL

Items 41-50 of 69

Page
per page